| Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients L Quagliata, MS Matter, S Piscuoglio, L Arabi, C Ruiz, A Procino, M Kovac, ... Hepatology 59 (3), 911-923, 2014 | 442 | 2014 |
| Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin L Arabi, A Badiee, F Mosaffa, MR Jaafari Journal of controlled release 220, 275-286, 2015 | 177 | 2015 |
| Doxorubicin-loaded composite nanogels for cancer treatment M Mohammadi, L Arabi, M Alibolandi Journal of controlled release 328, 171-191, 2020 | 82 | 2020 |
| Redox-sensitive nanoscale drug delivery systems for cancer treatment E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ... International journal of pharmaceutics 589, 119882, 2020 | 77 | 2020 |
| 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells SA Moosavian, K Abnous, J Akhtari, L Arabi, A Gholamzade Dewin, ... Artificial cells, nanomedicine, and biotechnology 46 (8), 2054-2065, 2018 | 60 | 2018 |
| Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model A Razazan, J Behravan, A Arab, N Barati, L Arabi, Z Gholizadeh, ... PloS one 12 (10), e0185099, 2017 | 55 | 2017 |
| Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma–reasons and consequences L Arabi, JR Gsponer, J Smida, M Nathrath, V Perrina, G Jundt, C Ruiz, ... Genes & cancer 5 (1-2), 56, 2014 | 41 | 2014 |
| Poly (I: C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model GA Talesh, Z Ebrahimi, A Badiee, M Mansourian, H Attar, L Arabi, ... Immunology letters 176, 57-64, 2016 | 35 | 2016 |
| Redox-sensitive doxorubicin liposome: A formulation approach for targeted tumor therapy E Mirhadi, M Mashreghi, A Askarizadeh, A Mehrabian, SH Alavizadeh, ... Scientific reports 12 (1), 11310, 2022 | 20 | 2022 |
| Immunoengineering in glioblastoma imaging and therapy S Zanganeh, P Georgala, C Corbo, L Arabi, JQ Ho, N Javdani, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 11 (6 …, 2019 | 20 | 2019 |
| Culture and drug profiling of patient derived malignant pleural effusions for personalized cancer medicine C Ruiz, S Kustermann, E Pietilae, T Vlajnic, B Baschiera, L Arabi, T Lorber, ... PLoS One 11 (8), e0160807, 2016 | 17 | 2016 |
| Stimulation of tumor-specific immunity by p5 HER-2/neu generated peptide encapsulated in nano-liposomes with high phase transition temperature phospholipids M Yazdani, S Amir Jalali, A Badiee, S Shariat, M Mansourian, L Arabi, ... Current drug delivery 14 (4), 492-502, 2017 | 15 | 2017 |
| Nanocarriers call the last shot in the treatment of brain cancers A Mehrabian, M Mashreghi, S Dadpour, A Badiee, L Arabi, ... Technology in Cancer Research & Treatment 21, 15330338221080974, 2022 | 14 | 2022 |
| Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy S Shahvali, N Rahiman, MR Jaafari, L Arabi Drug Delivery and Translational Research 13 (7), 2041-2056, 2023 | 12 | 2023 |
| Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis N Rahiman, M Mohammadi, SH Alavizadeh, L Arabi, A Badiee, ... Journal of Controlled Release 343, 620-644, 2022 | 11 | 2022 |
| Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy A Askarizadeh, M Mashreghi, E Mirhadi, F Mirzavi, VH Shargh, A Badiee, ... Cancer nanotechnology 14 (1), 18, 2023 | 9 | 2023 |
| Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data M Ghodousi, H Karbasforooshan, L Arabi, S Elyasi European Journal of Clinical Pharmacology 79 (1), 15-38, 2023 | 8 | 2023 |
| Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma V Jahani, M Yazdani, A Badiee, MR Jaafari, L Arabi Journal of Controlled Release 354, 453-464, 2023 | 6 | 2023 |
| Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach A Mehrabian, R Vakili-Ghartavol, M Mashreghi, SS Saremi, A Badiee, ... Iranian Journal of Basic Medical Sciences 25 (3), 302, 2022 | 6 | 2022 |
| Nanotechnology and nanomedicine JQ Ho, L Arabi, M Basu, F Khaled, Y Gonzalez, D Ghegeliu, N Javdani, ... Nanomedicine for ischemic cardiomyopathy, 9-21, 2020 | 6 | 2020 |
